Previous close | 0.3500 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 0.4500 |
Strike | 15.00 |
Expiry date | 2024-05-17 |
Day's range | 0.3500 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
SEATTLE, May 09, 2024--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2024.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]